Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

40
Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
40
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

29
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
29
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

33
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
33
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

80
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
80
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

103
A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
103
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

40
Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
40

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

DaRenCa risk score: A prognostic model for recurrence in clear cell renal cell carcinoma.

BJUI compass·2026
Same author

[Late sequelae after major urological surgery].

Ugeskrift for laeger·2026
Same author

Management of Lymph Node-Positive Renal Cell Carcinoma: Updated Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel.

European urology·2026
Same author

Hyperosmolarity of mouse urine confounds research in urinary tract infection.

Lab animal·2026
Same author

[Contrast-induced acute kidney injury after prostatic artery embolization].

Ugeskrift for laeger·2026
Same author

Response to: Bridging research and patient experience in chronic urinary tract infection.

BJU international·2026

Related Experiment Video

Updated: Sep 1, 2025

Establishment and Characterization of UTI and CAUTI in a Mouse Model
08:40

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Published on: June 23, 2015

20.2K

[Simple, recurrent, and complicated urinary tract infections].

Karin Andersen1, Louise Thomsen Schmidt Arenholt2, Kristian Stærk3

  • 1Urologisk Afdeling, Odense Universitetshospital.

Ugeskrift for Laeger
|August 12, 2022
PubMed
Summary

Urinary tract infections (UTIs) are caused by bacteria, leading to inflammation. This review explores UTI management and non-antibiotic treatments to combat rising antimicrobial resistance.

More Related Videos

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
07:57

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection

Published on: June 24, 2025

286
Isolation of Single Intracellular Bacterial Communities Generated from a Murine Model of Urinary Tract Infection for Downstream Single-cell Analysis
07:34

Isolation of Single Intracellular Bacterial Communities Generated from a Murine Model of Urinary Tract Infection for Downstream Single-cell Analysis

Published on: April 16, 2019

8.3K

Related Experiment Videos

Last Updated: Sep 1, 2025

Establishment and Characterization of UTI and CAUTI in a Mouse Model
08:40

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Published on: June 23, 2015

20.2K
An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection
07:57

An In Vitro Bladder Model of Catheter-Associated Urinary Tract Infection

Published on: June 24, 2025

286
Isolation of Single Intracellular Bacterial Communities Generated from a Murine Model of Urinary Tract Infection for Downstream Single-cell Analysis
07:34

Isolation of Single Intracellular Bacterial Communities Generated from a Murine Model of Urinary Tract Infection for Downstream Single-cell Analysis

Published on: April 16, 2019

8.3K

Area of Science:

  • Urology
  • Infectious Diseases
  • Microbiology

Background:

  • Urinary tract infections (UTIs) involve bacterial colonization causing inflammation.
  • Increasing antimicrobial resistance poses significant challenges for patient care and public health.
  • Recurrent UTIs require novel management strategies beyond traditional antibiotics.

Purpose of the Study:

  • To define simple, recurrent, and complicated urinary tract infections.
  • To review current examination and treatment recommendations for UTIs.
  • To explore emerging non-antibiotic alternatives for managing recurrent UTIs and reducing antimicrobial resistance.

Main Methods:

  • Literature review of definitions, diagnostics, and therapeutics for UTIs.
  • Analysis of current clinical guidelines and treatment protocols.
  • Exploration of scientific literature on non-antibiotic UTI management strategies.

Main Results:

  • Clear definitions provided for different UTI classifications.
  • Current diagnostic and treatment approaches outlined.
  • Promising non-antibiotic alternatives identified for future UTI management.

Conclusions:

  • Effective management of UTIs requires precise classification and appropriate treatment.
  • Addressing antimicrobial resistance is crucial for the future of UTI care.
  • Non-antibiotic alternatives offer a promising avenue for managing recurrent UTIs.